134 related articles for article (PubMed ID: 24751319)
1. Both body weight and BMI predicts improvement in symptom and functioning for patients with major depressive disorder.
Lin CH; Chen CC; Wong J; McIntyre RS
J Affect Disord; 2014 Jun; 161():123-6. PubMed ID: 24751319
[TBL] [Abstract][Full Text] [Related]
2. The relationship between symptom relief and functional improvement during acute fluoxetine treatment for patients with major depressive disorder.
Lin CH; Chou LS; Chen MC; Chen CC
J Affect Disord; 2015 Aug; 182():115-20. PubMed ID: 25985380
[TBL] [Abstract][Full Text] [Related]
3. Relief of depression and pain improves daily functioning and quality of life in patients with major depressive disorder.
Lin CH; Yen YC; Chen MC; Chen CC
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Dec; 47():93-8. PubMed ID: 23989033
[TBL] [Abstract][Full Text] [Related]
4. Early improvement in HAMD-17 and HAMD-6 scores predicts ultimate response and remission for depressed patients treated with fluoxetine or ECT.
Lin HS; Lin CH
J Affect Disord; 2019 Feb; 245():91-97. PubMed ID: 30368075
[TBL] [Abstract][Full Text] [Related]
5. Comparison of physician-rating and self-rating scales for patients with major depressive disorder.
Lin CH; Lu MJ; Wong J; Chen CC
J Clin Psychopharmacol; 2014 Dec; 34(6):716-21. PubMed ID: 25310200
[TBL] [Abstract][Full Text] [Related]
6. Predictors of fluoxetine remission for hospitalized patients with major depressive disorder.
Lin CH; Lane HY; Chen CC; Juo SH; Yen CF
Psychiatry Clin Neurosci; 2011 Aug; 65(5):510-7. PubMed ID: 21851460
[TBL] [Abstract][Full Text] [Related]
7. Melancholic features in inpatients with major depressive disorder associate with differential clinical characteristics and treatment outcomes.
Lin CH; Huang CJ; Liu SK
Psychiatry Res; 2016 Apr; 238():368-373. PubMed ID: 26899817
[TBL] [Abstract][Full Text] [Related]
8. The association of body mass index (BMI) with treatment outcomes in patients with major depressive disorder.
Xiao L; Zhou J; Galling B; Chen RS; Wang G
J Affect Disord; 2021 Feb; 281():799-804. PubMed ID: 33243554
[TBL] [Abstract][Full Text] [Related]
9. Early improvement in HAMD-17 and HAMD-7 scores predict response and remission in depressed patients treated with fluoxetine or electroconvulsive therapy.
Lin CH; Park C; McIntyre RS
J Affect Disord; 2019 Jun; 253():154-161. PubMed ID: 31035216
[TBL] [Abstract][Full Text] [Related]
10. The relationship between early changes in the HAMD-17 anxiety/somatization factor items and treatment outcome among depressed outpatients.
Farabaugh A; Mischoulon D; Fava M; Wu SL; Mascarini A; Tossani E; Alpert JE
Int Clin Psychopharmacol; 2005 Mar; 20(2):87-91. PubMed ID: 15729083
[TBL] [Abstract][Full Text] [Related]
11. ECT Has Greater Efficacy Than Fluoxetine in Alleviating the Burden of Illness for Patients with Major Depressive Disorder: A Taiwanese Pooled Analysis.
Lin CH; Huang CJ; Chen CC
Int J Neuropsychopharmacol; 2018 Jan; 21(1):63-72. PubMed ID: 29228200
[TBL] [Abstract][Full Text] [Related]
12. Psychosocial functioning during the treatment of major depressive disorder with fluoxetine.
Papakostas GI; Petersen T; Denninger JW; Tossani E; Pava JA; Alpert JE; Nierenberg AA; Fava M
J Clin Psychopharmacol; 2004 Oct; 24(5):507-11. PubMed ID: 15349006
[TBL] [Abstract][Full Text] [Related]
13. Do baseline WAIS-III subtests predict treatment outcomes for depressed inpatients receiving fluoxetine?
Lin CH; Chou LS; Tang SH; Huang CJ
Psychiatry Res; 2019 Jan; 271():279-285. PubMed ID: 30513459
[TBL] [Abstract][Full Text] [Related]
14. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
[TBL] [Abstract][Full Text] [Related]
15. Factors related to the improvement in quality of life for depressed inpatients treated with fluoxetine.
Yang WC; Lin CH; Wang FC; Lu MJ
BMC Psychiatry; 2017 Aug; 17(1):309. PubMed ID: 28841824
[TBL] [Abstract][Full Text] [Related]
16. Pain Affects Clinical Patterns and Treatment Outcomes for Patients With Major Depressive Disorder Taking Fluoxetine.
Lin HS; Wang FC; Lin CH
J Clin Psychopharmacol; 2015 Dec; 35(6):661-6. PubMed ID: 26479220
[TBL] [Abstract][Full Text] [Related]
17. Fluoxetine treatment of depressed patients with comorbid anxiety disorders.
Sonawalla SB; Farabaugh A; Johnson MW; Morray M; Delgado ML; Pingol MG; Rosenbaum JF; Fava M
J Psychopharmacol; 2002 Sep; 16(3):215-9. PubMed ID: 12236627
[TBL] [Abstract][Full Text] [Related]
18. Pain has a strong negative impact on the fluoxetine response in hospitalized patients with major depressive disorder.
Lin CH; Lane HY; Chen CC; Juo SH; Yen CF
Clin J Pain; 2011; 27(9):805-10. PubMed ID: 21677571
[TBL] [Abstract][Full Text] [Related]
19. Antidepressant response and well-being in pre-, peri- and postmenopausal women with major depressive disorder treated with fluoxetine.
Cassano P; Soares CN; Cusin C; Mascarini A; Cohen LS; Fava M
Psychother Psychosom; 2005; 74(6):362-5. PubMed ID: 16244512
[TBL] [Abstract][Full Text] [Related]
20. Obesity among outpatients with major depressive disorder.
Papakostas GI; Petersen T; Iosifescu DV; Burns AM; Nierenberg AA; Alpert JE; Rosenbaum JF; Fava M
Int J Neuropsychopharmacol; 2005 Mar; 8(1):59-63. PubMed ID: 15361263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
